… FOR COVID-19 The long-term effect of COVID-19 is still largely unknown. However, based
on the previous experiences with other viral pulmonary infections, long-term pulmonary …

… COVID-19 is a pulmonary infection disease caused by SARS-CoV-2. This virus can
reproduce in bronchiole mucosa or alveolar epithelial cells, resulting in mixed injury of …

… Additionally, pulmonary function tests before COVID-19 infection are not available for our …
of COVID-19 consequences in terms of pulmonary function. In conclusion, COVID-19 …

… Whether or not, any of these criteria can help in distinguishing Aspergillus colonization
from infection in COVID-19 patients is as yet uncertain. Indeed, an intrinsic part of severe …

… of pulmonary capillary leak syndrome is an exercise of exclusion. In our COVID‐19 department,
the diagnosis of pulmonary capillary leak syndrome following COVID‐19 virus infection …

… New patient assessment tools during and after COVID-19 infection, such as the COVID-19 …
In conclusion, a significant proportion of patients recovering from COVID-19 infection have …

… severity of pulmonary fibrosis associated with COVID-19. … the complications of COVID-19
infection and their treatment. … of pulmonary fibrosis associated with COVID-19 based on the …

… with COVID-19. The immune mechanism underlying diffuse alveolar and pulmonary
interstitial inflammation in COVID-19 … , has also been reported in coronavirus family infection. …

… the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection.
… Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans is …

… With this, we will present current evidence of invasive fungal infections in COVID-19
patients and existing debate on clinical features of the disease. We will then provide possible …